SCHEMBL17796265

SCHEMBL17796265

N#Cc1ccc(F)cc1[O]

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV4 Q9HBA0 3/20 0.42
▸ MAOA P21397 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ CYP11B2 P19099 3/20 0.40
▸ CYP11B1 P15538 2/20 0.40
▸ AR P10275 1/20 0.38
▸ FFAR4 Q5NUL3 2/20 0.38
▸ FFAR1 O14842 1/20 0.38
▸ USP8 P40818 1/20 0.36
▸ USP7 Q93009 1/20 0.36
▸ USP47 Q96K76 1/20 0.36
▸ SLC22A12 Q96S37 2/20 0.35
▸ MEN1 O00255 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17796275 0.82 TRPV4 (0.38) TRPV4MAOAMAOBCYP11B2CYP11B1
SCHEMBL573864 0.78 MAOB (0.53) TRPV4MAOAMAOBCYP11B2CYP11B1
SCHEMBL21131569 0.76 TRPV4 (0.45) TRPV4MAOAMAOBCYP11B2CYP11B1
SCHEMBL57346 0.76 TRPV4 (0.61) TRPV4MAOAMAOBCYP11B2CYP11B1
SCHEMBL30919072 0.76 TRPV4 (0.61) TRPV4MAOAMAOBCYP11B2CYP11B1
SCHEMBL3027684 0.76 IMPDH2 (0.42) TRPV4ALDH1A1
Ethylene SCHEMBL27960950 0.74 MAOB (0.50) TRPV4MAOAMAOBCYP11B2CYP11B1
SCHEMBL404482 0.73 ALDH1A1 (0.44) TRPV4MAOAMAOBCYP11B2CYP11B1
SCHEMBL20159095 0.73 TRPV4 (0.47) TRPV4MAOAMAOBCYP11B2CYP11B1
SCHEMBL2639674 0.73 TRPV4 (0.42) TRPV4MAOAMAOBCYP11B2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3029030-B1 TETRAZOLINONE COMPOUND, AND USE THEREFOR SUMITOMO CHEMICAL CO (JP) 2019-09-04 — — EP disclosed
US-9512090-B2 Tetrazolinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-12-06 — — US disclosed
US-20160159755-A1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-06-09 — — US disclosed
EP-3029030-A1 TETRAZOLINONE COMPOUND, AND USE THEREFOR Sumitomo Chemical Company, Limited (JP) 2016-06-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160159755-A1 TETRAZOLINONE COMPOUND AND USE THEREOF CYP1A1, CASP1, TCOF1 TRPV4 2025/4885MAOA 2054/4885MAOB 2237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback